208 related articles for article (PubMed ID: 16044027)
1. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
Ge J; Han Y; Jiang H; Sun B; Chen J; Zhang S; Du Z;
J Cardiovasc Pharmacol; 2005 Aug; 46(2):162-6. PubMed ID: 16044027
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
Kamishirado H; Inoue T; Mizoguchi K; Uchida T; Nakata T; Sakuma M; Takayanagi K; Morooka S
Am Heart J; 2002 Aug; 144(2):303-8. PubMed ID: 12177649
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
[TBL] [Abstract][Full Text] [Related]
4. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
Tanabe Y; Ito E; Nakagawa I; Suzuki K
Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
[TBL] [Abstract][Full Text] [Related]
5. Effects of cilostazol on angiographic restenosis after coronary stent placement.
Park SW; Lee CW; Kim HS; Lee NH; Nah DY; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 2000 Sep; 86(5):499-503. PubMed ID: 11009265
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
Park SW; Lee CW; Kim HS; Lee HJ; Park HK; Hong MK; Kim JJ; Park SJ
Am J Cardiol; 1999 Sep; 84(5):511-4. PubMed ID: 10482146
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
Yoon Y; Shim WH; Lee DH; Pyun WB; Kim IJ; Jang Y; Cho SY
Am J Cardiol; 1999 Dec; 84(12):1375-80. PubMed ID: 10606107
[TBL] [Abstract][Full Text] [Related]
8. [Effects of cilostazol on long-term clinical outcomes after coronary stenting].
Han YL; Wang SL; Li Y; Jing QM; Ma YY; Deng J; Yang GT; Yu HB; Ge JB
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):814-7. PubMed ID: 16316558
[TBL] [Abstract][Full Text] [Related]
9. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS.
Tsuchikane E; Takeda Y; Nasu K; Awata N; Kobayashi T
Catheter Cardiovasc Interv; 2004 Sep; 63(1):44-51. PubMed ID: 15343566
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
[TBL] [Abstract][Full Text] [Related]
11. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
Sekiguchi M; Hoshizaki H; Adachi H; Ohshima S; Taniguchi K; Kurabayashi M
Circ J; 2004 Jul; 68(7):610-4. PubMed ID: 15226623
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
Takeyasu N; Watanabe S; Noguchi Y; Ishikawa K; Fumikura Y; Yamaguchi I
Circ J; 2005 Jul; 69(7):780-5. PubMed ID: 15988102
[TBL] [Abstract][Full Text] [Related]
13. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
[TBL] [Abstract][Full Text] [Related]
14. Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
Zuliani Mauro MF; Mangione JA; Costa JR; Costa R; Piva E Mattos LA; Staico R; Feres F; Siqueira D; Sousa A; Abizaid A
J Invasive Cardiol; 2017 Mar; 29(3):76-81. PubMed ID: 28255102
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cilostazol and clopidogrel after successful coronary stenting.
Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.
Tamhane U; Meier P; Chetcuti S; Chen KY; Rha SW; Grossman MP; Gurm H
EuroIntervention; 2009 Aug; 5(3):384-93. PubMed ID: 19736165
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.
Ahn Y; Jeong MH; Jeong JW; Kim KH; Ahn TH; Kang WC; Park CG; Kim JH; Chae IH; Nam CW; Hur SH; Bae JH; Kim KY; Oh SK
Circ J; 2008 Jan; 72(1):35-9. PubMed ID: 18159096
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
Lee SW; Ahn JM; Han S; Park GM; Cho YR; Lee WS; Jang JY; Kwon CH; Lee JY; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2013 Nov; 112(9):1328-34. PubMed ID: 23890573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
